Nav: Home

Current Prostate cancer News and Events

Current Prostate cancer News and Events, Prostate cancer News Articles.
Sort By: Most Relevant | Most Viewed
Page 1 of 25 | 1000 Results
Financial hardship in cancer: The role of health insurance literacy
A new American Cancer Society study links health insurance literacy with medical financial hardship as well as non-medical financial sacrifices among adult cancer survivors in the United States. (2019-10-17)
Exercise can now be prescribed like medicine for people with and beyond cancer
A new initiative called Moving Through Cancer -- led by Kathryn Schmitz, professor of public health sciences at Penn State College of Medicine -- is hoping to make the benefits of physical activity for people living with and beyond cancer more commonly known. (2019-10-16)
Oxygen in hyperbaric chamber provides relief after radiotherapy
Hyperbaric oxygen therapy (HBOT) can relieve self-reported symptoms and side-effects of radiotherapy against cancer in the pelvic region, a study shows. (2019-10-16)
New international exercise guidelines for cancer survivors
For the rising number of cancer survivors worldwide, there's growing evidence that exercise is an important part of recovery. (2019-10-16)
For low-risk thyroid cancer patients, less may be more for post-surgery surveillance
Patient self-advocacy is important, and although a maximizing preference may be advantageous in many situations, new research led by the University of Michigan Rogel Cancer Center shows that, in the case of long-term surveillance of treated, low-risk thyroid cancer, health care ''maximizers'' consume more health care resources -- such as doctor visits and diagnostic imaging tests -- which drive up costs without a clear improvement in outcomes. (2019-10-14)
Overweight before age 40 increases the cancer risk
The risk of cancer increases considerably if you gain weight before the age of 40. (2019-10-11)
Study provides insights on statins' link to lower prostate cancer risk
In a Cancer Medicine study of cancer-free men followed for a median of seven years, statin use was associated with a lower risk of developing prostate cancer. (2019-10-09)
Bioelectricity's promise for therapeutic targets in cancer
Bioelectricity of Cancer, a special issue of the peer-reviewed journal Bioelectricity, has just been published. (2019-10-09)
Lymphoma stage at diagnosis may predict when and where new cancer forms
Colorado study shows the stage at which lymphoma is originally diagnosed impacts the types of second cancers that may form after treatment. (2019-10-08)
Large, long-term study suggests link between eating mushrooms and a lower risk of prostate cancer
Results from the first long-term cohort study of more than 36,000 Japanese men over decades suggest an association between eating mushrooms and a lower risk of prostate cancer. (2019-10-07)
Treatment for 'low T' could someday come from a single skin cell, USC research shows
USC researchers have successfully grown human, testosterone-producing cells in the lab, paving the way to someday treat low testosterone with personalized replacement cells. (2019-10-07)
Scientists have identified the presence of cancer-suppressing cells in pancreatic cancer
Researchers have identified cells containing a protein called Meflin that has a role in restraining the progression of pancreatic cancer. (2019-10-07)
New insights into the genomic landscape of meningiomas identified FGFR3 in a subset of patients with favorable prognoses
The identification of oncogenic mutations has provided further insights into the tumorigenesis of meningioma and the possibility of targeted therapy. (2019-10-04)
Targeting regulator of mitochondrial cell death delivers anticancer activity
A novel anticancer molecule created by researchers at The Wistar Institute showed therapeutic activity in preclinical models of various cancer types. (2019-10-03)
Study: Biomarker in urine may offer noninvasive detection of prostate cancer
A research study published in the journal Neoplasia and led by principal investigator Nallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, has identified a novel prostate cancer gene fusion involving the KLK4 protein coding gene and KLKP1 pseudogene. (2019-10-02)
Cancer data provide insights into occurrence, overdiagnosis, and treatment advances
Investigators analyzed 40 years of cancer burden data and examined patterns of incidence and mortality for various cancers, finding examples for which incidence and mortality moved in concert and examples where discordance in incidence and mortality indicate that overdiagnosis may be at play. (2019-10-02)
First prostate cancer therapy to target genes delays cancer progression
For the first time, prostate cancer has been treated based on the genetic makeup of the cancer, resulting in delayed disease progression, delayed time to pain progression, and potentially extending lives in patients with advanced, metastatic prostate cancer, reports a large phase 3 trial. (2019-09-30)
Targeted therapy slows progression of advanced prostate cancer
Data from the PROfound trial, presented at the ESMO Congress 2019, show that olaparib delayed cancer progression by about four months compared to new hormonal agents (enzalutamide or abiraterone acetate) in patients with metastatic, pre-treated prostate cancer whose cancer cells had faulty DNA repair genes. (2019-09-30)
Modern chemo better than second targeted hormone therapy against resistant prostate cancer
A modern chemotherapy drug is more effective for men with advanced prostate cancer than a second targeted hormone therapy in patients who have stopped responding to treatment, a major clinical trial shows. (2019-09-30)
ESMO 2019: Breast and ovarian cancer drug outperforms targeted hormone therapy in some men
A drug used for breast and ovarian cancer is more effective than modern targeted hormone treatments at slowing progression and improving survival in some men with advanced prostate cancer, phase III clinical trial findings reveal. (2019-09-30)
Men can be spared radiotherapy after surgery
Men with prostate cancer can be spared radiotherapy after surgery, according to late breaking results from a study led by The Royal Marsden NHS Foundation Trust. (2019-09-27)
Cancer tumours form surprising connections with healthy brain cells
Anti-epileptic medicine can curb the dangerous communication and possibly be part of future treatment. (2019-09-27)
Link between assisted reproduction and risk for prostate cancer
In a new national register study from Lund University in Sweden, researchers have studied the link between prostate cancer and infertility. (2019-09-26)
Trial finds high-dose radiation effective for men whose prostate cancer has spread
A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an effective and safe option for patients who wish to delay hormone-suppression therapy. (2019-09-26)
Semen miRNAs could be non-invasive biomarkers for prostate cancer
Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. (2019-09-26)
Long-term hormone tx increases mortality risk for men with low PSA after prostate surgery
A secondary analysis of a recent clinical trial that changed the standard of care for men with recurring prostate cancer finds long-term hormone therapy does more harm than good for many men and calls for rethinking treatment guidelines based on a patient's post-operative prostate-specific antigen (PSA) level. (2019-09-26)
Using the immune system as a defence against cancer
Research published today in the British Journal of Cancer has found that a naturally occurring molecule and a component of the immune system that can successfully target and kill cancer cells, can also encourage immunity against cancer resurgence. (2019-09-26)
Fathering children by assisted reproduction linked to increased risk of prostate cancer
Men who became fathers through assisted reproduction techniques seem to be at higher risk for prostate cancer and early onset prostate cancer compared with men achieving fatherhood naturally, concludes a study published by The BMJ today. (2019-09-25)
Study finds potential therapeutic target for prostate cancers with PTEN mutation
PTEN, a tumor suppressor gene mutated in about 20% of prostate cancers, relies on another gene, ARID4B, to function. (2019-09-24)
Survey reveals low levels of awareness in men about prostate health and function
Awareness of prostate health is alarmingly low in men over 50, a new survey commissioned by the European Association of Urology (EAU) has revealed, despite the fact that at the age of 60 and over, 40 percent of men suffer from an enlarged prostate. (2019-09-24)
Promising prostate cancer drug candidates identified by Bath scientists
Cancer researchers from the University of Bath have identified some promising drug candidates by using high-throughput screening methods to test tens of thousands of molecules. (2019-09-24)
Method discovered to reactivate tumour fighting genes 'silenced' by cancer
Scientists at UCL have developed a method to reactivate 'tumour suppressor' genes, which are switched off by cancer cells -- a finding which could lead to new targeted biotherapies for cancer. (2019-09-23)
Non-viral gene therapy to speed up cancer research
A new treatment method promises to speed up gene therapy research and could bring new, patient friendly cancer treatments to market faster. (2019-09-23)
New family of drugs which could combat prostate cancer identified at University of Bath
A new family of drugs which inhibit the activity of a protein associated with prostate and other cancers has been reported by scientists from the University of Bath. (2019-09-20)
Novel regulator of mitochondrial cell death reveals a promising target for cancer therapy
Wistar researchers have described the role of mitochondrial fission factor (MFF) in controlling survival of cancer cells, suggesting the protein could represent a promising therapeutic target. (2019-09-19)
Here's proof that bowel cancer screening reduces deaths
New research led by the University of South Australia shows just how effective bowel cancer screening is in helping to reduce the number of bowel cancer deaths by up to 45%. (2019-09-19)
3D virtual reality models help yield better surgical outcomes
A UCLA-led study has found that using three-dimensional virtual reality models to prepare for kidney tumor surgeries resulted in substantial improvements, including shorter operating times, less blood loss during surgery and a shorter stay in the hospital afterward. (2019-09-18)
Targeted radiotherapy technique could cut treatment time from two months to two weeks
Advanced radiotherapy technology could safely deliver curative treatment for some prostate cancer patients in just one or two weeks, according to new research published today. (2019-09-17)
Gene-targeted cancer drugs, slow release overcome resistance
Biomedical engineers at Duke University have developed a method to address failures in a promising anti-cancer drug, bringing together tools from genome engineering, protein engineering and biomaterials to improve the efficacy, accuracy and longevity of certain cancer therapies. (2019-09-16)
Meatballs might wreck the anti-cancer perks of tomato sauce
Some of the anti-cancer benefits of tomatoes, specifically those from a compound called lycopene, could disappear when they're eaten with iron-rich foods, according to a new study from The Ohio State University. (2019-09-16)
Page 1 of 25 | 1000 Results
   First   Previous   Next      Last   

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.